trabeculectomy with an antimetabolite was less likely to succeed. The Tube Versus Trabeculectomy (TVT) Study sought to determine whether earlier placement of glaucoma drainage implants would be a viable option in patients with uncomplicated glaucomas. 8 After one year of follow-up, the cumulative probability of failure was less for the non-valved 350mm 2 Baerveldt shunt group (3.9%) than for the trabeculectomy group (13.5%; p=0.017). 9 However, there was a greater need for supplemental medical therapy in the shunt group than in the trabeculectomy group to maintain similar IOP reductions at one year. 
Non-valved Shunts to Extraocular Reservoirs
The original non-valved shunt was developed by Molteno in 1969 with a round plate. 3 The prototype evolved into the multiple variations that are currently available (see Figure 1 ). To further reduce IOP, a double-plate version was developed. 10 It also comes in a ridge version with division of the top of the plate into two areas in an effort to reduce hypotony. 11 14 an intraluminal temporary stent, 15 prolene around the tip in the anterior chamber for later laser suturelysis, 16 or a combination of techniques. 17 The 2008 CPT code for insertion of these shunts is 66180 with revision of these shunts being 66185.
Valved Shunts to Extraocular Reservoirs
The first valved shunts were developed by Krupin in 1976 Figure 2 ). The original model has expanded into multiple sizes and an optional second plate. The material has evolved from the polypropylene plate to a thinner, tapered silicone plate. 22 CPT code for insertion of valved shunts is 66180, with revision of these shunts being 66185.
Alternative Locations for Shunt Placement
The standard placement of shunts is in the superior temporal quadrant with the tube inserted into the anterior chamber at the limbus. An alternative location is often chosen if the anterior chamber is shallow, the cornea is compromised, a penetrating keratoplasty is present, the conjunctiva is prohibitively scarred, or the tube has eroded through the conjunctiva. When the anterior chamber is not an option for tube placement, the tube can be inserted into the ciliary sulcus in pseudophakic or aphakic eyes. 25 Another alternative is through the pars plana in conjunction with a complete vitrectomy. 26 Standard shunts have been successfully inserted into the vitreous cavity and, more recently, tube shunts have been modified with a bend for insertion through the sclerostomy into the vitreous cavity (see Figure 3) . 27 In addition, a pars plana clip is available to assist in guiding the tube through the pars plana. 28 A shunt that was originally inserted into the anterior chamber may be repositioned into the vitreous cavity following a complete vitrectomy if anterior segment problems develop, such as corneal decompensation or recurrent erosions. 29 Another option for revising a shunt is to lengthen the tube with a tube extender, and select an alternative site for insertion. A tube extender is commercially available. 30 The tube has also been lengthened by splicing the tube with a 22-gauge angiocatheter and securing it with a 10-0 prolene suture. 31 
Innovations in Glaucoma Drainage Implants
While our armamentarium of glaucoma drainage implants to extraocular reservoirs has served us well over the past decades, there is determination among glaucomatologists to improve the current technology. Specifically, the glaucoma surgical paradigm is shifting toward procedures that are more reproducible, with lower blebs and fewer complications. To that end, a variety of new aqueous drainage devices are being developed to facilitate aqueous outflow in a manner that is both safe and efficacious (see Figure 4 ). There are three drainage units that are being actively employed in the US and/or Europe, and these will be discussed below. . 33 While this new procedure is promising, a prospective, randomized study needs to be performed to better define its strengths compared with trabeculectomy.
While the traditional approach to glaucoma surgery has been to lower the IOP by diverting aqueous into the subconjunctival space, novel strategies favor a technique that will decrease IOP without creating a bleb. This would enable IOP lowering without the bleb-related complications such as dysesthesia and leaks. To this end, the suprachoroidal space is a potential target into which fluid can be shunted. The theory is to create a shunt that Surgery Glaucoma The most common reported complication was transient hyphema, with no cases of long-term hypotony or post-operative infections. 34 While the results are encouraging, the FDA is awaiting further clinical studies.
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Figure 1: Examples of Non-valved Shunts to Extraocular Reservoirs
Another strategy that has gained significant attention is 'trabecular bypass.'
It is based on the observation that half of the outflow resistance in the normal eye is secondary to the trabecular meshwork and inner wall of Schlemm's canal. 35, 36 Thus, any mechanism that is employed to bypass this 
